The total life expectancy at birth in Malaysia increased by 1.2 years (+1.59 percent) in 2023. With 76.66 years, the life expectancy at birth thereby reached its highest value in the observed period. Life expectancy at birth refers to the number of years the average newborn is expected to live, providing that mortality patterns at the time of birth do not change thereafter.Find more statistics on other topics about Malaysia with key insights such as infant mortality rate, male smoking rate, and crude birth rate.

Women have a higher life expectancy than men in Sweden. Moreover, it increased for both gender over the past 10 years. For people born between 2019 and 2023, the life expectancy for men and women was 81.21 and 84.69 years, respectively. Sweden has one of the highest life expectancy levels worldwide.

San Marino Life Expectancy at Birth: Male data was reported at 84.100 Year in 2012. San Marino Life Expectancy at Birth: Male data is updated yearly, averaging 84.100 Year from Dec 2012 (Median) to 2012, with 1 observations. San Marino Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s San Marino – Table SM.World Bank.WDI: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

This table contains forecast figures from the period survival tables (per period of 1 year) by gender and age (on 31 December) for the population of the Netherlands. The table shows how many boys or girls from a group of 100,000 newborns will reach the age of 0, 1, 2, etc. on December 31 of the year of observation. It is also possible to see how old these children will be on average. The table can be broken down into mortality probability, the number of people alive (table population), the number of deaths (table population) and life expectancy by gender and age. Data available: 2012-2060 Status of the figures: The figures in this table are calculated forecast figures. Changes as of December 13, 2012. In this new table, the previous forecast has been adjusted based on the most recent insights, the forecast period now runs from 2012 to 2060. Changes as of December 16, 2014. Discontinued. When will new numbers come out? In December 2014, the new forecast figures will be published in a new table.

This statistic shows the female average life expectancy at birth in Macao from 2012 to 2022. In 2022, a new born female child in Macao had an average life expectancy of **** years.

San Marino Life Expectancy at Birth: Female data was reported at 86.800 Year in 2012. San Marino Life Expectancy at Birth: Female data is updated yearly, averaging 86.800 Year from Dec 2012 (Median) to 2012, with 1 observations. San Marino Life Expectancy at Birth: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s San Marino – Table SM.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

BackgroundWhile combination antiretroviral therapy (cART) has significantly improved survival times for persons diagnosed with HIV, estimation of life expectancy (LE) for this cohort remains a challenge, as mortality rates are a function of both time since diagnosis and age, and mortality rates for the oldest age groups may not be available.MethodsA validated case-finding algorithm for HIV was used to update the cohort of HIV-positive adults who had entered care in Ontario, Canada as of 2012. The Chiang II abridged life table algorithm was modified to use mortality rates stratified by time since entering the cohort and to include various methods for extrapolation of the excess HIV mortality rates to older age groups.ResultsAs of 2012, there were approximately 15,000 adults in care for HIV in Ontario. The crude all-cause mortality rate declined from 2.6% (95%CI 2.3, 2.9) per year in 2000 to 1.3% (1.2, 1.5) in 2012. Mortality rates were elevated for the first year of care compared to subsequent years (rate ratio of 2.6 (95% CI 2.3, 3.1)). LE for a 20-year old living in Ontario was 62 years (expected age at death is 82), while LE for a 20-year old with HIV was estimated to be reduced to 47 years, for a loss of 15 years of life. Ignoring the higher mortality rates among new cases introduced a modest bias of 1.5 additional years of life lost. In comparison, using 55+ as the open-ended age group was a major source of bias, adding 11 years to the calculated LE.ConclusionsUse of age limits less than the expected age at death for the open-ended age group significantly overstates the estimated LE and is not recommended. The Chiang II method easily accommodated input of stratified mortality rates and extrapolation of excess mortality rates.

The average number of years a newborn can expect to live, assuming he or she experiences the currently prevailing rates of death through their lifespan. Source: Baltimore City Health Department Years Available: 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018

The total life expectancy at birth in the United States saw no significant changes in 2023 in comparison to the previous year 2022 and remained at around 78.39 years. However, 2023 marked the second consecutive increase of the life expectancy at birth. These figures refer to the expected lifespan of the average newborn in a given country or region, providing that mortality patterns at the time of birth remain constant thereafter.Find more statistics on other topics about the United States with key insights such as crude birth rate, life expectancy of women at birth, and life expectancy of men at birth.

Greenland GL: Life Expectancy at Birth: Total data was reported at 71.830 Year in 2013. This records an increase from the previous number of 71.299 Year for 2012. Greenland GL: Life Expectancy at Birth: Total data is updated yearly, averaging 65.783 Year from Dec 1978 (Median) to 2013, with 36 observations. The data reached an all-time high of 71.830 Year in 2013 and a record low of 63.075 Year in 1981. Greenland GL: Life Expectancy at Birth: Total data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Greenland – Table GL.World Bank.WDI: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision, or derived from male and female life expectancy at birth from sources such as: (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Mortality experience data from 2010 through 2014 on private pension plans in the United States

General health expectancy estimates by sex, at birth and age 65, for Northern Ireland by country, national deciles of area deprivation and local government districts.

BackgroundChina's rapid economic and social development since the early 2000s has caused significant shifts in its epidemiological transition, potentially leading to health disparities across regions.ObjectivesThis study employs Life Expectancy (LE) to assess health disparities and trends among China's eastern, central, and western regions. It also examines the pace of LE gains relative to empirical trends and investigates age and causes of death mortality improvement contributing to regional LE gaps.Data and methodsUsing a log-quadratic model, the study estimates LE in China and its regions from 2004 to 2020, using census and death cause surveillance data. It also utilizes the Human Mortality Database (HMD) and the LE gains by LE level approach to analyze China and its regions' LE gains in comparison to empirical trend of developed countries. The study investigates changes in LE gaps due to age and causes of death mortality improvements during two periods, 2004–2012 and 2012–2020, through the LE factor decomposition method.ResultsFrom 2000 to 2020, China's LE exhibited faster pace of gains compared to developed countries. While men's LE growth gradually aligns with empirical trends, women experience slightly higher growth rates. Regional LE disparities significantly reduced from 2004 to 2012, with a marginal reduction from 2012 to 2020. In the latter period, the changing LE gap aligns with expected trends in developed countries, with all Chinese regions surpassing empirical estimates. Cardiovascular diseases and malignant neoplasms emerged as the primary contributors to expanding regional LE gaps, with neurological disorders and diabetes playing an increasingly negative role.ConclusionLE disparities in China have consistently decreased, although at a slower pace in recent years, mirroring empirical trends. To further reduce regional LE disparities, targeted efforts should focus on improving mortality rates related to cardiovascular diseases, neoplasms, neurological disorders and diabetes, especially in the western region. Effective health interventions should prioritize equalizing basic public health services nationwide.

BackgroundChina's rapid economic and social development since the early 2000s has caused significant shifts in its epidemiological transition, potentially leading to health disparities across regions.ObjectivesThis study employs Life Expectancy (LE) to assess health disparities and trends among China's eastern, central, and western regions. It also examines the pace of LE gains relative to empirical trends and investigates age and causes of death mortality improvement contributing to regional LE gaps.Data and methodsUsing a log-quadratic model, the study estimates LE in China and its regions from 2004 to 2020, using census and death cause surveillance data. It also utilizes the Human Mortality Database (HMD) and the LE gains by LE level approach to analyze China and its regions' LE gains in comparison to empirical trend of developed countries. The study investigates changes in LE gaps due to age and causes of death mortality improvements during two periods, 2004–2012 and 2012–2020, through the LE factor decomposition method.ResultsFrom 2000 to 2020, China's LE exhibited faster pace of gains compared to developed countries. While men's LE growth gradually aligns with empirical trends, women experience slightly higher growth rates. Regional LE disparities significantly reduced from 2004 to 2012, with a marginal reduction from 2012 to 2020. In the latter period, the changing LE gap aligns with expected trends in developed countries, with all Chinese regions surpassing empirical estimates. Cardiovascular diseases and malignant neoplasms emerged as the primary contributors to expanding regional LE gaps, with neurological disorders and diabetes playing an increasingly negative role.ConclusionLE disparities in China have consistently decreased, although at a slower pace in recent years, mirroring empirical trends. To further reduce regional LE disparities, targeted efforts should focus on improving mortality rates related to cardiovascular diseases, neoplasms, neurological disorders and diabetes, especially in the western region. Effective health interventions should prioritize equalizing basic public health services nationwide.

Over the period 2007-2011, life expectancy at birth was 78.5 years for the total population in New Mexico, 75.8 years for males, and 81.3 years for females.For comparison, in 2011, life expectancy at birth was 78.7 years for the total U.S. population, 76.3 years for males, and 81.1 years for females. (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6335a8.htm?s_cid=mm6335a8_e )PLEASE NOTE: The data in this map corrects, updates and replaces life expectancy data included in the 2012 Bernalillo County Place Matters 'Community Health Equity Report'. Compare life expectancy in Europe and the USA - Map ImageNOTE: Changes in life expectancy (Increase, Decrease, No Change) over the periods 1999-2003 to 2007-2011 are tested for statistical significance using a rule of one standard deviation.

Life Expectancy at Birth, Small Areas, by Sex, 1999-2003 and 2007-2011 - LEBSASEX

Summary: Life Expectancy at Birth, Small Areas, by Sex, 1999-2003 and 2007-2011

Prepared by: NEW MEXICO COMMUNITY DATA COLLABORATIVE, http://nmcdc.maps.arcgis.com/home/index.html ; T Scharmen, thomas.scharmen@state.nm.us, 505-897-5700 x126,

Data Sources: New Mexico Death Certificate Database, Office of Vital Records and Statistics, New Mexico Department of Health; Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program, http://bber.unm.edu/bber_research_demPop.html. Retrieved Mon, 21 June 2014 from New Mexico Department of Health, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.nm.us

Shapefile: http://nmcdc.maps.arcgis.com/home/item.html?id=1e97d2715d8640ab9023fa35fc7b2634

Feature: http://nmcdc.maps.arcgis.com/home/item.html?id=3104749c2c094044914abf9ba6953eab

Master File:

NM DATA VARIABLE DEFINITION

999 SANO Small Area Number

NEW MEXICO SANAME Small Area Name

9250534 PB9903 Population at Risk, Both Sexes, 1999-2003

77.7 LEB9903 Life Expectancy at Birth, Both Sexes, 1999-2003

77.7 CILB9903 Lower Confidence Interval for Life Expectancy at Birth, Both Sexes, 1999-2003

77.7 CIUB9903 Upper Confidence Interval for Life Expectancy at Birth, Both Sexes, 1999-2003

10188104 PB0711 Population at Risk, Both Sexes, 2007-2011

78.5 LEB0711 Life Expectancy at Birth, Both Sexes, 2007-2011

78.5 CILB0711 Lower Confidence Interval for Life Expectancy at Birth, Both Sexes, 2007-2011

78.5 CIUB0711 Upper Confidence Interval for Life Expectancy at Birth, Both Sexes, 2007-2011

0.8 LEBDIFF Difference in Life Expectancy, Both Sexes, 2007-2011 MINUS 1999-2003

INCREASE LEBSIG Trend of the Difference in Life Expectancy, Both Sexes, (1 standard deviation = 68.2% confidence interval)

4683013 PF9903 Population at Risk, Females, 1999-2003

80.6 LEF9903 Life Expectancy at Birth, Females, 1999-2003

80.6 CILF9903 Lower Confidence Interval for Life Expectancy at Birth, Females, 1999-2003

80.6 CIUF9903 Upper Confidence Interval for Life Expectancy at Birth, Females, 1999-2003

5155192 PF0711 Population at Risk, Females, 2007-2011

81.3 LEF0711 Life Expectancy at Birth, Females, 2007-2011

81.3 CILF0711 Lower Confidence Interval for Life Expectancy at Birth, Females, 2007-2011

81.3 CIUF0711 Upper Confidence Interval for Life Expectancy at Birth, Females, 2007-2011

0.7 LEFDIFF Difference in Life Expectancy, Females, 2007-2011 MINUS 1999-2003

INCREASE LEFSIG Trend of the Difference in Life Expectancy, Females, (1 standard deviation = 68.2% confidence interval)

4567521 PM9903 Population at Risk, Males, 1999-2003

74.8 LEM9903 Life Expectancy at Birth, Males, 1999-2003

74.8 CILM9903 Lower Confidence Interval for Life Expectancy at Birth, Males, 1999-2003

74.8 CIUM9903 Upper Confidence Interval for Life Expectancy at Birth, Males, 1999-2003

5032911 PM0711 Population at Risk, Males, 2007-2011

75.8 LEM0711 Life Expectancy at Birth, Males, 2007-2011

75.7 CILM0711 Lower Confidence Interval for Life Expectancy at Birth, Males, 2007-2011

75.8 CIUM0711 Upper Confidence Interval for Life Expectancy at Birth, Males, 2007-2011

1 LEMDIFF Difference in Life Expectancy, Males, 2007-2011 MINUS 1999-2003

INCREASE LEMSIG Trend of the Difference in Life Expectancy, Males, (1 standard deviation = 68.2% confidence interval)

1.077540107 FMRT9903 Female to Male Ratio of Life Expectancy, 1999-2003

1.072559367 FMRT0711 Female to Male Ratio of Life Expectancy, 2007-2011

5.8 FMDT9903 Female Life Expectancy MINUS Male Life Expectancy, 1999-2003

5.5 FMDT0711 Female Life Expectancy MINUS Male Life Expectancy, 2007-2011

-0.3 FMDTDIFF Difference in Female Life Expectancy MINUS Male Life Expectancy, over both time periods, in Years

This table contains 2754 series, with data for years 2005/2007 - 2012/2014 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (153 items: Canada; Newfoundland and Labrador; Eastern Regional Integrated Health Authority, Newfoundland and Labrador; Central Regional Integrated Health Authority, Newfoundland and Labrador; ...); Age group (2 items: At birth; At age 65); Sex (3 items: Both sexes; Males; Females); Characteristics (3 items: Life expectancy; Low 95% confidence interval, life expectancy; High 95% confidence interval, life expectancy).

Objective Gains in life expectancy have faltered in several high-income countries in recent years. We aim to compare life expectancy trends in Scotland to those seen internationally, and to assess the timing of any recent changes in mortality trends for Scotland. Setting Austria, Croatia, Czech Republic, Denmark, England & Wales, Estonia, France, Germany, Hungary, Iceland, Israel, Japan, Korea, Latvia, Lithuania, Netherlands, Northern Ireland, Poland, Scotland, Slovakia, Spain, Sweden, Switzerland, USA. Methods We used life expectancy data from the Human Mortality Database (HMD) to calculate the mean annual life expectancy change for 24 high-income countries over five-year periods from 1992 to 2016, and the change for Scotland for five-year periods from 1857 to 2016. One- and two-break segmented regression models were applied to mortality data from National Records of Scotland (NRS) to identify turning points in age-standardised mortality trends between 1990 and 2018. Results In 2012-2016 life expectancies in Scotland increased by 2.5 weeks/year for females and 4.5 weeks/year for males, the smallest gains of any period since the early 1970s. The improvements in life expectancy in 2012-2016 were smallest among females (<2.0 weeks/year) in Northern Ireland, Iceland, England & Wales and the USA and among males (<5.0 weeks/year) in Iceland, USA, England & Wales and Scotland. Japan, Korea, and countries of Eastern Europe have seen substantial gains in the same period. The best estimate of when mortality rates changed to a slower rate of improvement in Scotland was the year to 2012 Q4 for males and the year to 2014 Q2 for females. Conclusion Life expectancy improvement has stalled across many, but not all, high income countries. The recent change in the mortality trend in Scotland occurred within the period 2012-2014. Further research is required to understand these trends, but governments must also take timely action on plausible contributors. Description of methods used for collection/generation of data: The HMD has a detailed methods protocol available here: https://www.mortality.org/Public/Docs/MethodsProtocol.pdf The ONS and NRS also have similar methods for ensuring data consistency and quality assurance. Methods for processing the data: The segmented regression was conducted using the 'segmented' package in R. The recommended references to this package and its approach are here: Vito M. R. Muggeo (2003). Estimating regression models with unknown break-points. Statistics in Medicine, 22, 3055-3071. Vito M. R. Muggeo (2008). segmented: an R Package to Fit Regression Models with Broken-Line Relationships. R News, 8/1, 20-25. URL https://cran.r-project.org/doc/Rnews/. Vito M. R. Muggeo (2016). Testing with a nuisance parameter present only under the alternative: a score-based approach with application to segmented modelling. J of Statistical Computation and Simulation, 86, 3059-3067. Vito M. R. Muggeo (2017). Interval estimation for the breakpoint in segmented regression: a smoothed score-based approach. Australian & New Zealand Journal of Statistics, 59, 311-322. Software- or Instrument-specific information needed to interpret the data, including software and hardware version numbers: The analyses were conducted in R version 3.6.1 and Microsoft Excel 2013. Please see README.txt for further information HMD international_updated Jan 2019.xlsx Comprises 20 worksheets, of which 14 contain data. These data are arranged by country and by year. Missing data codes: "" The tab 'contents and sources' provides descriptions of the data source and contents of each sheet. HMD Scotland time trend analysis.xlsx Comprises 5 worksheets, including a combination of data and charts. The sheet 'contents' describes the data source and contents of other sheets. The variables include year, life expectancy, and various measures of change in life expectancy Missing data codes: "" Segmented regression chart.xlsx Comprises 2 worksheets, 'Data' and 'Chart'. Variables within the 'data' worksheet include: Year 4 quarter rolling period ending Female observed mortality rate Female predicted by one-break model Female predicted by two-break model Male observed mortality rate Male predicted by one-break model Male predicted by two-break model Chart breakpoint indicator Missing data codes: (blank space) Summary findings from segmented regression.xlsx Excel workbook containing table 1 of paper 'summary of results of segmented regression by population group and model/test'

This dataset shows the life expectancy at regional level for 2011.

Life expectancy in the EU, which is a reflection of well-being, is among the highest in the world. Of the 50 countries in the world with the highest life expectancy in 2012, 21 were EU Member States, 18 of which had a higher life expectancy than the US. Differences between regions in the EU are marked. Life expectancy at birth is less than 74 in many partsof Bulgaria as well as in Latvia and Lithuania, while overall across the EU it is over 80 years in two out of every three regions. In 17 regions in Spain, France and Italy, it is 83 years or more.

EU-28 = 80.3 . BE, IT, UK: 2010. Source: Eurostat